Although we excluded patients with acute infections and liver dysfunction, it is important to acknowledge that prealbumin remains a negative acute-phase reactant, and subclinical inflammation or unrecognized hepatic factors may still influence its levels to some extent. This evidence concerns the gene TTR and Decreased liver function.